Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.91 USD | +1.54% | +7.95% | +8.54% |
02:14pm | Stifel Starts Phathom Pharmaceuticals With Buy Rating, $24 Price Target | MT |
03-07 | Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Neutral |
Resistance | 10.45 | 12.05 | 15.59 |
Spread/Res. | -5.17% | -17.76% | -36.43% |
Spread/Supp. | +10.48% | +16.73% | +47.03% |
Support | 8.970 | 8.490 | 6.740 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PHAT Stock
- Charts Phathom Pharmaceuticals, Inc.